Global Nicotinamide Riboside (NR) Competitive Landscape Professional Research Report 2025
Research SummaryNicotinamide riboside (NR) is a form of vitamin B3, also known as niacin or nicotinic acid. It is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme that plays a crucial role in various cellular processes, including energy metabolism, DNA repair, and regulation of gene expression. NR can be found naturally in trace amounts in some foods like milk, yeast, and certain vegetables, but it is also available as a dietary supplement. Research suggests that NR supplementation may support cellular health and function by boosting NAD+ levels, which decline with age and in certain health conditions. Some potential benefits of NR supplementation include improved mitochondrial function, enhanced metabolism, and protection against age-related decline. However, further studies are needed to fully understand the effects and potential therapeutic applications of NR supplementation.
According to DIResearch's in-depth investigation and research, the global Nicotinamide Riboside (NR) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, Tiantai Biotechnology, EnzymeWorks, Suzhou MyLand Pharm & Nutrition, Shenzhen Ejion Biotechnology, Zhejiang Jiahua, Weitai Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Nicotinamide Riboside (NR). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nicotinamide Riboside (NR) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nicotinamide Riboside (NR) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nicotinamide Riboside (NR) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Nicotinamide Riboside (NR) Include:
ChromaDex
Genex Formulas
Shandong Tianming Pharmaceutical
Bontac
Longer Livetech
Tiantai Biotechnology
EnzymeWorks
Suzhou MyLand Pharm & Nutrition
Shenzhen Ejion Biotechnology
Zhejiang Jiahua
Weitai Pharmaceutical
Nicotinamide Riboside (NR) Product Segment Include:
Purity ≤98%
Purity >98%
Nicotinamide Riboside (NR) Product Application Include:
Health Supplement
Pharmaceutical Additives
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Nicotinamide Riboside (NR) Capacity and Production Analysis
Chapter 3: Global Nicotinamide Riboside (NR) Industry PESTEL Analysis
Chapter 4: Global Nicotinamide Riboside (NR) Industry Porter's Five Forces Analysis
Chapter 5: Global Nicotinamide Riboside (NR) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Nicotinamide Riboside (NR) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Nicotinamide Riboside (NR) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources